Література - глаукома

1. Sommer A, Tielsch JM, Katz J, et al. Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. Arch Ophthalmol 1991-109: 1090-1095.
2. CoffeyM, ReidyA, Wormald R, Xian WX, WrightL, Courtney P.The prevalence of glaucoma in the west of Ireland.Br J Ophthalmol 1993-77: 17-21.
3. Leske MC, Cornell AM, Wu SY, etal. Incidence of open-angle glaucoma: the Barbados Eye Studies. The Barbados Eye Studies Group. Arch Ophthalmol 2001-119: 89-95.
4. Government Statistical Service. Causes of blindness and partial sight amongst adults. London: HMSO, 1988.
5. Tielsch JM, Katz J, Quigley HA, et al. Diabetes, intraocular pressure, and primary open-angle glaucoma in the Baltimore Eye Survey. Ophthalmology 1995-102: 48-53.
6. Pandit RJ, Taylor R Mydriasis and glaucoma: exploding the myth. A systematic review. Diabet Med 2000- 17: 693- 699.
7. Sheldrick JH, Ng C, Austin DJ, Rosenthal AR. An analysis of referral routes and diagnostic accuracy in cases of suspected glaucoma. Ophthalmic Epidemiol 1994-1: 31-38.
8. FraserS, Bunce C, Wormald R, Brunner E. Deprivation and late presentation of glaucoma: case-control study. BMJ 2001-322: 639-643.
9. Jay JL, Murdoch JR The rates of visual field loss in untreated primary open angle glaucoma. Br J Ophthalmol 1993-77: 176-178.
10. RossettiL, Marchettil, OrzalesiN, Scorpiglione N, Torri V, ii&eraft`ARandomised clinical trials on medical treatment of glaucoma: are they appropriate to guide clinical practice? Arch Ophthalmol 1993-111: 96-103. Search date 1991- primary source Medline.
11. Diamond JP. Systemic adverse effects of topical ophthalmic agents: implications for older patients. Drags Aging 1997-11: 352-360.
12. Glaucoma Laser Trial Group. The glaucoma laser trial (GLT) and glaucoma laser trial follow-up study: results. Am J Ophthalmol 1995-120: 718-731.
13. Migdal З, Gregory W, Hitchins R, KolkerAE. Long-term functional outcome after early surgery compared with laser and medicine in open angle glaucoma. Ophthalmology 1994-101: 1651-1657.
14. The Advanced Glaucoma Intervention Study (AGIS): 4. Comparison of treatment outcomes within race. Seven year results. Ophthalmology 1998-105: 1146-1164.
15. Jay JL, Allan D. The benefit of early trabeculectomy versus conventional management in primary open angle glaucoma relative to severity of disease. Eye 1989-3: 528-535.
16. Costas UP, Smith M, Spaeth GL, Gondham S, Markovitz B. Loss of vision after trabeculectomy. Ophthalmology 1993-100: 599-612.
17. Collaborative normal-tension glaucoma study group. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressure. Am J Ophthalmol 1998-126: 487-497.
18. Collaborative normal-tension glaucoma study group. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol 1998-126: 498-505.
19. Edwards RS. A comparative study of Ocusert Klo 40, intensive pilocarpine and low-dose pilocarpine in the initial treatment of primary acute angle-closure glaucoma. Curr Med Res Opin 1997-13: 501-509.
20. Fleck BW, Wright E, Fairley EA. A randomised prospective comparison of operative peripheral iridectomy and Nd: YAG laser iridotomy treatment of acute angle closure glaucoma: 3 year visual acuity and intraocular pressure control outcome. Br J Ophthalmol 1997-81: 884-888.
21. Fleck BW, Dhillon B, Khanna V, Fairley E, McGfynn C. A randomised, prospective comparison of Nd: YAG laser iridotomy and operative peripheral iridectomy in fellow eyes.Eye 1991-5: 315-321.
22. Pollack IP, Robin AL, Dragon DM, et al. Use of neodymium: YAG laser to create iridotomies in monkeys and humans. Trans Am Ophthalmol Soc 1984-82: 307-328.
23. Moster MR, Schwartz L W, Spaeeth GL, Wilson RP, McAllister J A, Poryzees EM. Laser iridectomy. A controlled study comparing argon and neodymium: YAG. Ophthalmology 1986-93: 20-24.

Конфлікт інтересів: про конфлікт інтересів не повідомляється.